Section one: Contracting authority
one.1) Name and addresses
NHS England - North West
Regatta Place, Brunswick Business Park, Summers Road
Liverpool
L3 4BL
Country
United Kingdom
Region code
UKD - North West (England)
NHS Organisation Data Service
(Q75)
Internet address(es)
Main address
https://www.england.nhs.uk/north-west/contact-us/
one.1) Name and addresses
NHS England - North West Greater Manchester
4th floor Piccadilly place, London Road
MANCHESTER
M1 3BN
Country
United Kingdom
Region code
UKD - North West (England)
NHS Organisation Data Service
(Q83)
Internet address(es)
Main address
https://www.england.nhs.uk/north-west/contact-us/
one.2) Information about joint procurement
The contract involves joint procurement
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
NHSE1063-64 Mpox Vaccination and Gonorrhoea Vaccination
Reference number
NHSE1063-64
two.1.2) Main CPV code
- 85140000 - Miscellaneous health services
two.1.3) Type of contract
Services
two.1.4) Short description
NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.
Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement:
• a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK
• a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK
The Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population.
The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines.
Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme.
Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year.
As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years.
Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025.
Eligible providers must:
• Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process.
• Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire.
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
NHSE NW
• Lot 1 - Cheshire West & Chester
• Lot 2 - Blackburn with Darwen
• Lot 3 - Wirral
NHSE GM
• Lot 4 - Rochdale, Oldham, Bury
• Lot 5 - Tameside, Stockport, Wigan
• Lot 6 - Manchester, Trafford and Salford
• Lot 7 - Bolton- MPOX
two.1.6) Information about lots
This contract is divided into lots: Yes
two.1.7) Total value of the procurement (excluding VAT)
Lowest offer: £0.01 / Highest offer: £18.06 taken into consideration
two.2) Description
two.2.1) Title
Lot 1 - Cheshire West and Chester
Lot No
1
two.2.2) Additional CPV code(s)
- 85140000 - Miscellaneous health services
two.2.3) Place of performance
NUTS codes
- UKD - North West (England)
Main site or place of performance
Lot 1 - Cheshire West and Chester
two.2.4) Description of the procurement
NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.
Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement:
• a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK
• a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK
The Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population.
Eligibility
The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines.
Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme.
Activity/funding
Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year.
As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years.
Delivery date
Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025.
Provider Eligibility Criteria:
Eligible providers must:
• Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process.
• Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire.
Contract Term:
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
Locations/Lots:
NHSE NW
• Lot 1 - Cheshire West & Chester - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.
• Lot 2 - Blackburn with Darwen - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2026.
• Lot 3 - Wirral - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.
NHSE GM
• Lot 4 - Rochdale, Oldham, Bury - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.
• Lot 5 - Tameside, Stockport, Wigan - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.
• Lot 6 - Manchester, Trafford and Salford - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.
• Lot 7 - Bolton- MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 30 December 2031.
two.2.5) Award criteria
Quality criterion - Name: Patient Choice / Weighting: 100
Cost criterion - Name: Patient Choice / Weighting: 100
two.2.11) Information about options
Options: No
two.2.14) Additional information
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority
two.2) Description
two.2.1) Title
Lot 2 - Blackburn with Darwen
Lot No
2
two.2.2) Additional CPV code(s)
- 85140000 - Miscellaneous health services
two.2.3) Place of performance
NUTS codes
- UKD - North West (England)
Main site or place of performance
Lot 2 - Blackburn with Darwen
two.2.4) Description of the procurement
NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.
Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement:
• a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK
• a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK
The Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population.
Eligibility
The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines.
Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme.
Activity/funding
Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year.
As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years.
Delivery date
Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025.
Provider Eligibility Criteria:
Eligible providers must:
• Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process.
• Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire.
Contract Term:
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
Locations/Lots:
NHSE NW
• Lot 1 - Cheshire West & Chester - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.
• Lot 2 - Blackburn with Darwen - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2026.
• Lot 3 - Wirral - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.
NHSE GM
• Lot 4 - Rochdale, Oldham, Bury - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.
• Lot 5 - Tameside, Stockport, Wigan - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.
• Lot 6 - Manchester, Trafford and Salford - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.
• Lot 7 - Bolton- MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 30 December 2031.
two.2.5) Award criteria
Quality criterion - Name: Patient Choice / Weighting: 100
Cost criterion - Name: Patient Choice / Weighting: 100
two.2.11) Information about options
Options: No
two.2.14) Additional information
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority
two.2) Description
two.2.1) Title
Lot 3 - Wirral
Lot No
3
two.2.2) Additional CPV code(s)
- 85140000 - Miscellaneous health services
two.2.3) Place of performance
NUTS codes
- UKD - North West (England)
Main site or place of performance
Lot 3 - Wirral
two.2.4) Description of the procurement
NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.
Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement:
• a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK
• a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK
The Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population.
Eligibility
The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines.
Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme.
Activity/funding
Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year.
As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years.
Delivery date
Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025.
Provider Eligibility Criteria:
Eligible providers must:
• Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process.
• Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire.
Contract Term:
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
Locations/Lots:
NHSE NW
• Lot 1 - Cheshire West & Chester - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.
• Lot 2 - Blackburn with Darwen - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2026.
• Lot 3 - Wirral - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.
NHSE GM
• Lot 4 - Rochdale, Oldham, Bury - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.
• Lot 5 - Tameside, Stockport, Wigan - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.
• Lot 6 - Manchester, Trafford and Salford - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.
• Lot 7 - Bolton- MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 30 December 2031.
two.2.5) Award criteria
Quality criterion - Name: Patient Choice / Weighting: 100
Cost criterion - Name: Patient Choice / Weighting: 100
two.2.11) Information about options
Options: No
two.2.14) Additional information
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority
two.2) Description
two.2.1) Title
Lot 4 - Rochdale, Oldham, Bury
Lot No
4
two.2.2) Additional CPV code(s)
- 85140000 - Miscellaneous health services
two.2.3) Place of performance
NUTS codes
- UKD - North West (England)
Main site or place of performance
Lot 4 - Rochdale, Oldham, Bury
two.2.4) Description of the procurement
NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.
Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement:
• a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK
• a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK
The Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population.
Eligibility
The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines.
Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme.
Activity/funding
Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year.
As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years.
Delivery date
Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025.
Provider Eligibility Criteria:
Eligible providers must:
• Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process.
• Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire.
Contract Term:
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
Locations/Lots:
NHSE NW
• Lot 1 - Cheshire West & Chester - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.
• Lot 2 - Blackburn with Darwen - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2026.
• Lot 3 - Wirral - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.
NHSE GM
• Lot 4 - Rochdale, Oldham, Bury - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.
• Lot 5 - Tameside, Stockport, Wigan - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.
• Lot 6 - Manchester, Trafford and Salford - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.
• Lot 7 - Bolton- MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 30 December 2031.
two.2.5) Award criteria
Quality criterion - Name: Patient Choice / Weighting: 100
Cost criterion - Name: Patient Choice / Weighting: 100
two.2.11) Information about options
Options: No
two.2.14) Additional information
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority
two.2) Description
two.2.1) Title
Lot 5 - Tameside, Stockport, Wigan
Lot No
5
two.2.2) Additional CPV code(s)
- 85140000 - Miscellaneous health services
two.2.3) Place of performance
NUTS codes
- UKD - North West (England)
Main site or place of performance
Lot 5 - Tameside, Stockport, Wigan
two.2.4) Description of the procurement
NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.
Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement:
• a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK
• a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK
The Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population.
Eligibility
The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines.
Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme.
Activity/funding
Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year.
As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years.
Delivery date
Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025.
Provider Eligibility Criteria:
Eligible providers must:
• Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process.
• Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire.
Contract Term:
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
Locations/Lots:
NHSE NW
• Lot 1 - Cheshire West & Chester - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.
• Lot 2 - Blackburn with Darwen - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2026.
• Lot 3 - Wirral - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.
NHSE GM
• Lot 4 - Rochdale, Oldham, Bury - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.
• Lot 5 - Tameside, Stockport, Wigan - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.
• Lot 6 - Manchester, Trafford and Salford - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.
• Lot 7 - Bolton- MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 30 December 2031.
two.2.5) Award criteria
Quality criterion - Name: Patient Choice / Weighting: 100
Cost criterion - Name: Patient Choice / Weighting: 100
two.2.11) Information about options
Options: No
two.2.14) Additional information
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority
two.2) Description
two.2.1) Title
Lot 6 - Manchester, Trafford and Salford
Lot No
6
two.2.2) Additional CPV code(s)
- 85140000 - Miscellaneous health services
two.2.3) Place of performance
NUTS codes
- UKD - North West (England)
Main site or place of performance
Lot 6 - Manchester, Trafford and Salford
two.2.4) Description of the procurement
NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.
Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement:
• a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK
• a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK
The Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population.
Eligibility
The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines.
Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme.
Activity/funding
Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year.
As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years.
Delivery date
Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025.
Provider Eligibility Criteria:
Eligible providers must:
• Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process.
• Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire.
Contract Term:
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
Locations/Lots:
NHSE NW
• Lot 1 - Cheshire West & Chester - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.
• Lot 2 - Blackburn with Darwen - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2026.
• Lot 3 - Wirral - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.
NHSE GM
• Lot 4 - Rochdale, Oldham, Bury - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.
• Lot 5 - Tameside, Stockport, Wigan - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.
• Lot 6 - Manchester, Trafford and Salford - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.
• Lot 7 - Bolton- MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 30 December 2031.
two.2.5) Award criteria
Quality criterion - Name: Patient Choice / Weighting: 100
Cost criterion - Name: Patient Choice / Weighting: 100
two.2.11) Information about options
Options: No
two.2.14) Additional information
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority
two.2) Description
two.2.1) Title
Lot 7 - Bolton
Lot No
7
two.2.2) Additional CPV code(s)
- 85140000 - Miscellaneous health services
two.2.3) Place of performance
NUTS codes
- UKD - North West (England)
Main site or place of performance
Lot 7 - Bolton
two.2.4) Description of the procurement
NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.
Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement:
• a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK
• a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK
The Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population.
Eligibility
The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines.
Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme.
Activity/funding
Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year.
As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years.
Delivery date
Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025.
Provider Eligibility Criteria:
Eligible providers must:
• Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process.
• Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire.
Contract Term:
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
Locations/Lots:
NHSE NW
• Lot 1 - Cheshire West & Chester - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.
• Lot 2 - Blackburn with Darwen - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2026.
• Lot 3 - Wirral - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.
NHSE GM
• Lot 4 - Rochdale, Oldham, Bury - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.
• Lot 5 - Tameside, Stockport, Wigan - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.
• Lot 6 - Manchester, Trafford and Salford - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.
• Lot 7 - Bolton- MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 30 December 2031.
two.2.5) Award criteria
Quality criterion - Name: Patient Choice / Weighting: 100
Cost criterion - Name: Patient Choice / Weighting: 100
two.2.11) Information about options
Options: No
two.2.14) Additional information
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Award of a contract without prior publication of a call for competition in the cases listed below
- The procurement falls outside the scope of application of the regulations
Explanation:
The Relevant Authorities intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
Section five. Award of contract
Contract No
Lot 1 - Cheshire West and Chester
Lot No
Lot 1 - Cheshire West and Chester
Title
NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
29 July 2025
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
HCRG Care Services Limited
The Heath Business & Technical Park, Runcorn
Cheshire
WA7 4QX
Country
United Kingdom
NUTS code
- UKD - North West (England)
Companies House
07557877
Internet address
https://www.hcrgcaregroup.com/
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Total value of the contract/lot: £18.06
Section five. Award of contract
Contract No
Lot 2 - Blackburn with Darwen
Lot No
Lot 2 - Blackburn with Darwen
Title
NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
29 July 2025
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Brook Young People
Penhaligon House, Green Street,
Truro,
TR1 2LH
Country
United Kingdom
NUTS code
- UKK3 - Cornwall and Isles of Scilly
Companies House
02466940
Internet address
The contractor is an SME
Yes
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £18.06
Total value of the contract/lot: £18.06
Section five. Award of contract
Contract No
Lot 3 - Wirral
Lot No
Lot 3 - Wirral
Title
NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
29 July 2025
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Wirral Community Health and Care NHS Foundation Trust
Derby Road
Birkenhead
CH42 0LQ
Country
United Kingdom
NUTS code
- UKD - North West (England)
NHS Organisation Data Service
(RY7)
Internet address
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £18.06
Total value of the contract/lot: £18.06
Section five. Award of contract
Contract No
Lot 4 - Rochdale, Oldham, and Bury
Lot No
Lot 4 - Rochdale, Oldham, and Bury
Title
NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
29 July 2025
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
HCRG Care Services Limited
The Heath Business & Technical Park, Runcorn
Cheshire
WA7 4QX
Country
United Kingdom
NUTS code
- UKD - North West (England)
Companies House
07557877
Internet address
https://www.hcrgcaregroup.com/
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £18.06
Total value of the contract/lot: £18.06
Section five. Award of contract
Contract No
Lot 5 - Tameside, Stockport, and Wigan
Lot No
Lot 5 - Tameside, Stockport, and Wigan
Title
NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
29 July 2025
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Locala Community Partnerships CIC
Eddercliffe Health Centre, Bradford Road,
Liversedge
WF15 6LP
Country
United Kingdom
NUTS code
- UKE4 - West Yorkshire
Companies House
07584906
Internet address
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £18.06
Total value of the contract/lot: £18.06
Section five. Award of contract
Contract No
Lot 6 - Manchester, Trafford and Salford
Lot No
Lot 6 - Manchester, Trafford and Salford
Title
NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
29 July 2025
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Manchester University NHS Foundation Trust
Cobbett House, Oxford Road
MANCHESTER
M13 9W
Country
United Kingdom
NUTS code
- UKD - North West (England)
NHS Organisation Data Service
(R0A)
Internet address
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £18.06
Total value of the contract/lot: £18.06
Section five. Award of contract
Contract No
Lot 7 - Bolton
Lot No
Lot 7 - Bolton
Title
NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
4 August 2025
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Bolton NHS Foundation Trust
The Royal Bolton Hospital, Minerva Road, Farnworth
Bolton
BL4 0JR
Country
United Kingdom
NUTS code
- UKD - North West (England)
NHS Organisation Data Service
(RMC)
Internet address
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £18.06
Total value of the contract/lot: £18.06
Section six. Complementary information
six.3) Additional information
The Relevant Authorities intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.
Details of individual making decisions:
Public Health Senior Manager, Commissioning Directorate, NHS England - North West.
Public Health Manager (Commissioning), NHS England/ NHS Greater Manchester Integrated Care.
Screening and Immunisation Coordinator, GM S7a Screening and Immunisation Team, Population Health Directorate, NHS England Greater Manchester.
Assistant Director of Finance - Direct Commissioning, NHS Greater Manchester.
Finance Manager (Public Health, COVID & Medical Revalidation)
NHS England - North West.
There were no conflicts of interests identified.
six.4) Procedures for review
six.4.1) Review body
NHS England - North West
Regatta Place, Brunswick Business Park, Summers Road
Liverpool
L3 4BL
Country
United Kingdom